• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Roles of low muscle strength and sarcopenic obesity on incident symptomatic knee osteoarthritis

bySiwen LiuandAlex Chan
December 15, 2024
in Chronic Disease, Rheumatology
Reading Time: 4 mins read
Many new pediatric asthma cases attributable to obesity
Share on FacebookShare on Twitter

1. Low muscle strength, obesity, and sarcopenic obesity were associated with a greater risk of incident symptomatic knee osteoarthritis (OA) 7 years later in middle-aged and older Chinese adults. 

2. Muscle strength mediated the association between obesity and knee OA.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Age-related obesity has been linked with lower muscle mass and greater fat infiltration in muscles that could result in mechanical imbalances in knee joints, suggesting that lower muscle strength may mediate the impact of obesity on onset of knee osteoarthritis (OA). Sarcopenic obesity involves muscle loss combined with fat accumulation. Previous research found that obesity and sarcopenic obesity but not sarcopenia alone was associated with increased risk of knee OA, highlighting the importance of considering both conditions when assessing knee OA risk. However, research on sarcopenic obesity and knee OA is still limited. This study thus investigated the impact of muscle strength and sarcopenic obesity on knee OA onset and whether lower muscle strength mediates the link between obesity and knee OA in a middle- and old-age Chinese population. Of the 12,043 included in this prospective cohort study, 2,008 progressed to symptomatic knee OA during the 7-year follow-up. Results found that lower muscle strength (normalized grip strength and chair-rising time), obesity (general and abdominal), sarcopenic obesity was associated with an increased risk of symptomatic knee OA. Additionally, participants with sarcopenia obesity were about 2 times more at risk of incident knee OA than those with sarcopenia alone. Muscle strength mediated the relationship between obesity and knee OA incidence. Overall study findings suggest that improving muscle strength may mitigate knee OA risk in Chinese middle- to old-age adults with obesity. Future research is needed to validate study findings. 

Click to read the study in BMC Medicine 

Relevant reading: Risk of Knee Osteoarthritis With Obesity, Sarcopenic Obesity, and Sarcopenia

RELATED REPORTS

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

Joint fusion superior to watchful waiting for hallux rigidus 

The addition of leflunomide (Arava) to prednisone (Deltasone) may not improve rate of remission in Takayasu arteritis

In-Depth [Longitudinal cohort study]: This study investigated the impact of muscle strength and sarcopenic obesity on knee OA onset and whether lower muscle strength mediates the link between obesity and knee OA in a middle- and old-age Chinese population. This study analyzed baseline and 7-year follow-up data from the China Health and Retirement Longitudinal Study (CHARLS), a prospective cohort study including adults > 45 years old. Muscle strength and function were assessed by normalized grip strength and 5-time chair stand test, respectively. The study outcome was incidence of symptomatic knee OA, defined as both physician-diagnosed arthritis and the presence of concurrent pain in either knee joint. Out of the 12,043 included in this study (mean age = 58.66 ± 9.85 years, female = 6230 (51.7%), mean BMI = 23.48 ± 3.64 kg/m2), 2,008 progressed to knee OA during the 7-year follow-up (mean age = 58.94 ± 9.27 years, female 1227 (61%), mean BMI = 23.71 ± 3.74 kg/m2). General obesity (relative risk (RR): 1.23, 95% CI: 1.08 to 1.39) and abdominal obesity (RR:1.23, 95% CI: 1.11 to 1.35) both increased knee OA onset by 23% compared to participants with normal BMI and waist circumference, respectively. Participants with the highest level of normalized grip strength (> 0.65) at baseline had a 33% decreased risk of incident knee OA (RR:0.67, 95% CI: 0.60 to 0.75) compared to the group with lowest level of normalized grip strength (< 0.45). Participants with the greatest chair-rising time (>12.30) at baseline had a 65% increased risk of incident knee OA (RR:1.65, 95% CI: 1.17 to 2.33) compared to those with the lowest chair-rising times (< 7.80s). Associations remained significant even after adjusting for covariates. Based on BMI definitions of obesity, those with sarcopenia obesity (RR: 2.41, 95% CI: 1.78 to 3.26) were about 2 times more at risk of incident knee OA than those with sarcopenia alone (RR: 1.45, 95% CI: 1.22 to 1.74). The relationship between general obesity and incidence of knee OA was fully mediated by normalized grip strength (β = 0.064, 95% CI: 0.004 to 0.126) and chair-rising time (β = 0.013, 95% CI: 0.004 to 0.024). Additionally, the relationship between abdominal obesity and incidence of knee OA was 22% mediated by normalized grip strength (β = 0.013, 95% CI: 0.004 to 0.024) and 6.2% mediated by chair-rising time (β = 0.013, 95% CI: 0.004 to 0.024). Overall, study results found that low muscle strength and sarcopenic obesity are associated with increased risk of incidence of symptomatic knee OA and that muscle strength is a mediator between obesity and symptomatic knee OA incidence. These findings suggest that improving muscle strength may be effective in mitigating knee OA risk in Chinese middle- to old-age adults with general and/or abdominal obesity. To validate study findings, future research could assess how other measures of muscle quality and quantity relate to knee OA onset.

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: chronic diseaseendocrinologyobesityosteoarthritisrheumatology
Previous Post

Mental health symptoms of youth from higher-income households noted to be poorer during COVID-19 pandemic

Next Post

2 Minute Medicine Rewind December 16, 2024

RelatedReports

Reduced gestational weight gain with lifestyle intervention
Chronic Disease

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

September 2, 2026
Uninterrupted warfarin therapy safe for endovascular procedures
Orthopedic Surgery

Joint fusion superior to watchful waiting for hallux rigidus 

August 10, 2026
Lower target oxygen saturation in extremely preterm infants appears safe
Chronic Disease

The addition of leflunomide (Arava) to prednisone (Deltasone) may not improve rate of remission in Takayasu arteritis

July 10, 2026
Amyloid may cause distant cerebral hypometabolism in Alzheimer’s
Psychiatry

Glucosamine Linked to Faster Alzheimer’s Progression in Patients with Mild Cognitive Impairment

September 4, 2026
Next Post

2 Minute Medicine Rewind December 16, 2024

Preoperative bilateral breast imaging may reduce contralateral cancer recurrence

Addition of pembrolizumab to chemotherapy improves early-stage triple-negative breast cancer survival

Breast cancer chemoprevention may reduce mortality in lobular carcinoma-in-situ

Imlunestrant with or without Abemaciclib in Advanced Breast Cancer

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • High maternal egg-peanut intake not associated with reduced infant allergy
  • The rotavirus vaccine (ROTASIIL) may reduce the incidence of hospitalization for rotavirus gastroenteritis in children
  • Emergency department triaging decisions supported by artificial intelligence (AI) led to improved triaging accuracy and patient flow
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.